by John Herdman | Jan 19, 2025 | Uncategorized
By John W. Herdman, Ph.D. (John Herdman ) Ketamine, a drug once confined to surgical and veterinary settings, is becoming a topic of dual intrigue and concern. While its clinical potential as a breakthrough therapy for treatment-resistant depression has garnered...
by herdmanhealth_7bak7e | May 6, 2023 | Uncategorized
HerdmanHealth, a healthcare tech company, now offers the Addiction Severity Index (ASI) and ASI-LITE assessments for counselors and psychologists. ASI evaluates substance use disorders in individuals, while ASI-LITE is a quick screening tool. Their platform completes...
